Alliance Pharma COO stepping down, position to be disestablished.

Healthcare products group Alliance Pharma announced on Tuesday that its chief operating officer Jeyan Heper would leave the company on 31 August.

Alliance Pharma
23 July 2024 12:13:55

Source: Sharecast

The AIM-traded firm said Heper joined on 1 February 2023, playing a significant role in identifying growth opportunities in international consumer healthcare markets and assisting the board and senior executive team in developing strategies for markets, especially in China and the US.

In a move to accelerate globalisation, bring consumers closer to the core of the business, and streamline the management structure, the board said it had decided to eliminate the COO position.

“I want to thank Jeyan for his contribution to Alliance, providing stability and valuable international consumer healthcare insights as we continue on our journey to transform to a high performing consumer healthcare company, built on a portfolio of leading, trusted and proven brands,” said chief executive officer Nick Sedgwick.

“We wish him well in his future endeavours.”

At 1140 BST, shares in Alliance Pharma were down 0.54% at 36.8p.

Reporting by Josh White for Sharecast.com.

N/A

ISIN: N/A

Exchange: N/A

Sell:

N/A

Buy:

N/A

Change:

Date:

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.